Cargando…
Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics
Prostate cancer (PCa) is the most frequently diagnosed cancer worldwide and the second most common cause of cancer-related deaths among men. Progress in molecular imaging has magnified its clinical management; however, an unmet clinical need involves the identification of new imaging biomarkers that...
Autores principales: | Laudicella, Riccardo, Spataro, Alessandro, Crocè, Ludovica, Giacoppo, Giulia, Romano, Davide, Davì, Valerio, Lopes, Maria, Librando, Maria, Nicocia, Antonio, Rappazzo, Andrea, Celesti, Greta, Torre, Flavia La, Pagano, Benedetta, Garraffa, Giuseppe, Bauckneht, Matteo, Burger, Irene A, Minutoli, Fabio, Baldari, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047910/ https://www.ncbi.nlm.nih.gov/pubmed/36980482 http://dx.doi.org/10.3390/diagnostics13061175 |
Ejemplares similares
-
Prostate Cancer Biochemical Recurrence Resulted Negative on [(68)Ga]Ga-PSMA-11 but Positive on [(18)F]Fluoromethylcholine PET/CT
por: Laudicella, Riccardo, et al.
Publicado: (2022) -
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature
por: Guglielmo, Priscilla, et al.
Publicado: (2023) -
[(68)Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [(177)Lu]DOTATOC PRRT: The “Theragnomics” Concept
por: Laudicella, Riccardo, et al.
Publicado: (2022) -
Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination
por: Laudicella, Riccardo, et al.
Publicado: (2021) -
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review
por: Sidrak, Marko Magdi Abdou, et al.
Publicado: (2023)